FDA — authorised 29 February 1988
- Application: NDA019599
- Marketing authorisation holder: LEGACY PHARMA
- Local brand name: NAFTIN
- Indication: CREAM — TOPICAL
- Status: approved
FDA authorised NAFT-600 ( naftin 2 % gel ) on 29 February 1988
Yes. FDA authorised it on 29 February 1988; FDA authorised it on 18 June 1990.
LEGACY PHARMA holds the US marketing authorisation.